{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:54:31Z","timestamp":1776664471039,"version":"3.51.2"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Uterine mesonephric-like adenocarcinoma (MLA) is a rare and biologically aggressive subtype of endometrial carcinoma, estrogen receptor (ER) and progesterone receptor (PR) are typically absent or exhibit very low expression in this type of cancer. The cornerstone of treatment is still surgical resection, frequently in combination with chemotherapy or radiation therapy. There is currently disagreement over the optimal therapeutic regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 60-year-old postmenopausal woman presented with vaginal bleeding as the initial symptom. Computed tomography (CT) imaging revealed a uterine mass, and postoperative histopathology confirmed a diagnosis of mesonephric-like adenocarcinoma of the uterus. This case demonstrates dual ER\/PR positivity, representing the first reported instance of this rare clinical subtype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study aims to enhance clinicians\u2019 recognition and management of uterine mesonephric-like adenocarcinoma. MLA with hormone receptor expression may exhibit distinct biological behavior. Future studies with larger cohorts and longer follow-up are needed to explore whether these tumors could represent a candidate for endocrine-based therapeutic approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1787557","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:25:19Z","timestamp":1776662719000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Hormone receptor-positive uterine mesonephric-like adenocarcinoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Ting","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Oncology, The Research Institute of Integrated TCM & Western Medicine of Chengdu University of Chinese Medicine, Chengdu Integrated TCM and Western Medicine Hospital","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianing","family":"Shen","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chengdu Integrated TCM and Western Medicine Hospital","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Research Institute of Integrated TCM & Western Medicine of Chengdu University of Chinese Medicine, Chengdu Integrated TCM and Western Medicine Hospital","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nie","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Research Institute of Integrated TCM & Western Medicine of Chengdu University of Chinese Medicine, Chengdu Integrated TCM and Western Medicine Hospital","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/jcm10040698","article-title":"Mesonephric-like adenocarcinoma of the endometrium: diagnostic advances to spot this wolf in sheep\u2019s clothing. A review of the literature.","volume":"10","author":"Deolet","year":"2021","journal-title":"J Clin Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/pas.0000000000001873","article-title":"Mesonephric-like endometrial carcinoma: results from immunohistochemical screening of 300 endometrial carcinomas and carcinosarcomas for this often overlooked and potentially aggressive entity.","volume":"46","author":"Mills","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"526","DOI":"10.21873\/cgp.20338","article-title":"Mesonephric-like adenocarcinoma of the uterine corpus: comprehensive analyses of clinicopathological, molecular, and prognostic characteristics with retrospective review of 237 endometrial carcinoma cases.","volume":"19","author":"Kim","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/dc.25111","article-title":"Cytological features of mesonephric-like adenocarcinoma of the uterine corpus.","volume":"51","author":"Seo","year":"2023","journal-title":"Diagn Cytopathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1097\/pas.0000000000001142","article-title":"Comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract.","volume":"42","author":"Pors","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/diagnostics11081450","article-title":"Mesonephric-like differentiation of endometrial endometrioid carcinoma: clinicopathological and molecular characteristics distinct from those of uterine mesonephric-like adenocarcinoma.","volume":"11","author":"Park","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1097\/pas.0000000000000471","article-title":"GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract.","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/PAS.0000000000001612","article-title":"Clinicopathologic characteristics of mesonephric adenocarcinomas and mesonephric-like adenocarcinomas in the gynecologic tract: a multi-institutional study.","volume":"45","author":"Pors","year":"2021","journal-title":"Am J Surg Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/bjc.2015.207","article-title":"Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1.","volume":"113","author":"Sgaramella","year":"2015","journal-title":"Br J Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/his.12332","article-title":"Thyroid transcription factor-1 (TTF-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus.","volume":"64","author":"Ervine","year":"2014","journal-title":"Histopathology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1177\/1066896920901764","article-title":"Collision tumor of endometrial large cell neuroendocrine carcinoma and low-grade endometrial stromal sarcoma: a case report and review of the literature.","volume":"28","author":"Rivera","year":"2020","journal-title":"Int J Surg Pathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"802","DOI":"10.4103\/IJPM.IJPM_701_20","article-title":"Uterine collision tumor of endometrial stromal sarcoma and endometrioid adenocarcinoma: a rare case report and review of literature.","volume":"64","author":"Sharma","year":"2021","journal-title":"Indian J Pathol Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1244261","DOI":"10.3389\/fonc.2023.1244261","article-title":"Uterine collision tumor (PEComa and endometrioid carcinoma) in a tuberous sclerosis patient: a case report.","volume":"13","author":"Koufopoulos","year":"2023","journal-title":"Front Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.18597\/rcog.4011","article-title":"Uterine collision tumor. Case report and review of the literature.","volume":"74","author":"Ruiz-Echeverr\u00eda","year":"2023","journal-title":"Rev Colomb Obstet Ginecol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","article-title":"Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases.","volume":"34","author":"Da Silva","year":"2021","journal-title":"Mod Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.3802\/jgo.2019.30.e13","article-title":"The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.","volume":"30","author":"Guan","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ygyno.2024.01.015","article-title":"Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: a single-center experience with molecular characterization, treatment, and oncologic outcomes.","volume":"182","author":"Praiss","year":"2024","journal-title":"Gynecol Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1634\/theoncologist.2015-0511","article-title":"Comprehensive genomic profiling aids in distinguishing metastatic recurrence from second primary cancers.","volume":"22","author":"Weinberg","year":"2017","journal-title":"Oncologist."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1055\/a-1545-4279","article-title":"2020 WHO classification of female genital tumors.","volume":"81","author":"H\u00f6hn","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"B21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/pas.0000000000001401","article-title":"Mesonephric-like carcinoma of the endometrium: a subset of endometrial carcinoma with an aggressive behavior.","volume":"44","author":"Euscher","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1212648","DOI":"10.3389\/fonc.2023.1212648","article-title":"Case report: the first report of PPP2R1A mutations in mesonephric-like adenocarcinoma of endometrial carcinoma.","volume":"13","author":"Cai","year":"2023","journal-title":"Front Oncol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1787557\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:25:21Z","timestamp":1776662721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1787557\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":22,"alternative-id":["10.3389\/fmed.2026.1787557"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1787557","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1787557"}}